GLO1 and Parkinson disease: Also, another identified modulator lrk-1/LRRK2 and its counterpart glo-1/RAB29 have been previously associated together in PD pathogenesis, but the role of RAB29 in αSyn pathology has not been validated (Kalogeropulou et al., 2020).